Amicus Therapeutics 10K Form

Sell

25

FOLD
Amicus Therapeutics

Last Price:

9.52

Seasonality Move:

7.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	FOLD/Amicus Therapeutics Quarterly
2023-11-08	10Q	FOLD/Amicus Therapeutics Quarterly
2023-08-08	10Q	FOLD/Amicus Therapeutics Quarterly
2023-05-10	10Q	FOLD/Amicus Therapeutics Quarterly
2022-11-07	10Q	FOLD/Amicus Therapeutics Quarterly
2022-08-04	10Q	FOLD/Amicus Therapeutics Quarterly

Receive FOLD News And Ratings

See the #1 stock for the next 7 days that we like better than FOLD

FOLD Financial Statistics

Sales & Book Value

Annual Sales:	$399.36M
Cash Flow:	$-23.33M
Price / Cash Flow:	0
Annual Sales:	$0.60
Price / Book:	16.14

Profitability

EPS (TTM):	-0.34000
Net Income (TTM):	$-104.69M
Gross Margin:	$362.03M
Return on Equity:	-71.17%
Return on Assets:	-13.78%

Amicus Therapeutics Earnings Forecast

Key Amicus Therapeutics Financial Ratios

The Gross Profit Margin over the past 21 years for FOLD is 90.65%.
The Selling, General & Administrative Expenses for FOLD have been equal to 68.93% of Gross Profit Margin.
The Research & Development expenses have been 38.16% of Revenue.
The Interest Expense is -33.08% of Operating Income.
The Net Earning history of FOLD is -37.96% of Total Revenues.
Per Share Earnings over the last 21 years have been positive in 11 years.

Amicus Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	FOLD
CUSIP:	03152W
Website:	amicusrx.com

Debt

Debt-to-Equity Ratio:	2.18
Current Ratio:	3.15
Quick Ratio:	2.2

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	25.49

FOLD Technical Analysis vs Fundamental Analysis

Sell

25

Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy or a Sell?

Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $9.59. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.